Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 5Crohn Disease 4Colitis, Ulcerative 4Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Inflammatory Bowel Diseases 3Colitis 3Arthritis, Rheumatoid 3Urogenital Neoplasms 2Inflammation 2Hematologic Neoplasms 2Graft vs Host Disease 2Fatigue 2Depressive Disorder, Major 2Depression 2Cachexia 2Anorexia 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Skin Neoplasms 1Recurrence 1Rare Diseases 1Pemphigoid, Benign Mucous Membrane 1Pancreatic Neoplasms 1Lymphoma 1Kidney Transplantation 1Hypertension 1

Interventions

Nutrition Assessment 3Transcranial Direct Current Stimulation 2urinastatin 1tocilizumab 1rimabotulinumtoxinB 1X-Rays 1Vitamin B 6 1Vitamin B 12 1Thrombectomy 1Standard of Care 1Saline Solution 1Rosuvastatin Calcium 1Resistance Training 1Practice Guidelines as Topic 1Phenylephrine 1Palliative Care 1Norepinephrine 1Music Therapy 1Massage 1Lysine Acetyltransferase 5 1Infliximab 1Immunoglobulin G 1Folic Acid 1Extracorporeal Shockwave Therapy 1Exergaming 1Enoxaparin 1Disulfides 1Dialectical Behavior Therapy 1Cholecalciferol 1Cerebral Angiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stroke × Infliximab × Clear all
NCT02638701 2025-07-08

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

University of California, San Francisco

Phase 1/2 Recruiting
8 enrolled

Aneurysm, Vasculitis, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡